<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0260">
 <label>51</label>
 <element-citation publication-type="journal" id="rf0250">
  <person-group person-group-type="author">
   <name>
    <surname>Oâ€™Brien</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Chandran</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Weatherholtz</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Jafri</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Griffin</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Bellamy</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial</article-title>
  <source>Lancet Infect Dis</source>
  <volume>15</volume>
  <issue>12</issue>
  <year>2015</year>
  <fpage>1398</fpage>
  <lpage>1408</lpage>
  <ext-link ext-link-type="uri" xlink:href="pmid:26511956" id="ir0335" xmlns:xlink="http://www.w3.org/1999/xlink">26511956</ext-link>
  <pub-id pub-id-type="pmid">26511956</pub-id>
 </element-citation>
</ref>
